Boyalife, a global biopharmaceutical holding company, launches a number of projects in Binhu district, Wuxi. [photo/neau.edu.cn]

Wuxi’s biomedical research and development service outsourcing zone in Binhu district will become the site of 15 high-end projects in the medical and health sectors, according to an announcement at the Taihu (Mashan) Life Science and Healthcare Forum on April 12.

A project from the United Kingdom will focus on early tumor detection, while a joint project launched by Boyalife Group and Wuxi People's Hospital will promote stem cell research and related clinical applications.

In addition, Boyalife Group will cooperate with Wuxi Science and Technology Bureau to set up a cell therapy industry alliance to integrate medical resources and upgrade the biomedical industry, a key strategic emerging industry in Binhu district.